Medicine recalls
|
| |
| The United Kingdom: Class 2 Medicines Recall: Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Syri Limited, T/A SyriMed is recalling 2 batches of Baclofen 10mg/5ml Oral Solution (batch number: EBB24001A1, EBB25001A1) as a precautionary measure due to crystallisation observed over time in the oral solution. Testing results show that the assay of the filtered oral solution does not comply with the licensed specification of the product and there is a potential risk of sub-therapeutic dosing. The recall is at pharmacy and wholesaler level.
The product is indicated for the relief of spasticity of voluntary muscle resulting from such disorders as: multiple sclerosis, other spinal lesions, e.g. syringomyelia, motor neurone disease, transverse myelitis. It is also indicated for the relief of spasticity of voluntary muscle arising from e.g. cerebrovascular accidents, cerebral palsy, meningitis, traumatic head injury.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-26-a-slash-06
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by MHRA, and was posted on the Drug Office website on 26 Nov 2024.
Ends/Wednesday, Feb 4, 2026
Issued at HKT 15:45
|
| |
|
